Deep phenotyping of p.(V142I)‐associated variant transthyretin amyloid cardiomyopathy: Distinct from wild‐type transthyretin amyloidosis?

MLA

Razvi, Yousuf, et al. “Deep Phenotyping of p.(V142I)‐associated Variant Transthyretin Amyloid Cardiomyopathy: Distinct from Wild‐type Transthyretin Amyloidosis?” European Journal of Heart Failure, vol. 26, no. 2, Feb. 2024, pp. 383–93. EBSCOhost, https://doi.org/10.1002/ejhf.3088.

APA

Razvi, Y., Ioannou, A., Patel, R. K., Chacko, L., Karia, N., Riefolo, M., Porcari, A., Rauf, M. U., Starr, N., Ganesananthan, S., Blakeney, I., Kaza, N., Filisetti, S., Bolhuis, R. E., Rowczenio, D., Gilbertson, J., Hutt, D., Mahmood, S., Lachmann, H. J., & Wechalekar, A. D. (2024). Deep phenotyping of p.(V142I)‐associated variant transthyretin amyloid cardiomyopathy: Distinct from wild‐type transthyretin amyloidosis? European Journal of Heart Failure, 26(2), 383–393. https://doi.org/10.1002/ejhf.3088

Chicago

Razvi, Yousuf, Adam Ioannou, Rishi K. Patel, Liza Chacko, Nina Karia, Mattia Riefolo, Aldostefano Porcari, et al. 2024. “Deep Phenotyping of p.(V142I)‐associated Variant Transthyretin Amyloid Cardiomyopathy: Distinct from Wild‐type Transthyretin Amyloidosis?” European Journal of Heart Failure 26 (2): 383–93. doi:10.1002/ejhf.3088.